Deferred Tax Assets, Valuation Allowance of Mosaic ImmunoEngineering Inc. from 31 May 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Mosaic ImmunoEngineering Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 May 2012 to 31 Dec 2024.
  • Mosaic ImmunoEngineering Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $3,504,861, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Mosaic ImmunoEngineering Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $3,504,861 +$354,000 +11% 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q4 2023 $3,150,861 +$324,397 +11% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q4 2022 $2,826,464 +$708,591 +33% 31 Dec 2022 10-K 15 Apr 2024 2023 FY
Q4 2021 $2,117,873 +$1,086,334 +105% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q4 2020 $1,031,539 31 Dec 2020 10-K 26 Jan 2022 2021 FY
Q2 2020 $0 -$3,693,088 -100% 31 May 2020 10-KT 02 Mar 2021 2020 FY
Q2 2019 $3,693,088 $0 0% 31 May 2019 10-K 29 Aug 2019 2019 FY
Q2 2018 $3,693,088 31 May 2018 10-K 29 Aug 2018 2018 FY
Q2 2013 $15,566 +$10,198 +40% 31 May 2013 10-K 23 Aug 2013 2013 FY
Q2 2012 $25,764 31 May 2012 10-K 23 Aug 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.